Hansa Biopharma AB
🇳🇴Norway
- Country
- 🇳🇴Norway
- Ownership
- Public
- Established
- 2007-01-01
- Employees
- 168
- Market Cap
- -
A Follow up Study of Patients Treated With Imlifidase Prior to Kidney Transplantation
Completed
- Conditions
- First Posted Date
- 2018-08-02
- Last Posted Date
- 2023-02-24
- Lead Sponsor
- Hansa Biopharma AB
- Target Recruit Count
- 39
- Registration Number
- NCT03611621
- Locations
- 🇺🇸
Cedars-Sinai Medical Center, Los Angeles, California, United States
🇺🇸New York University School of Medicine, New York, New York, United States
🇺🇸The Johns Hopkins Hospital, Baltimore, Maryland, United States
IdeS in Asymptomatic Antibody-Mediated Thrombotic Thrombocytopenic Purpura (TTP) Patients
Phase 2
Terminated
- Conditions
- Interventions
- First Posted Date
- 2016-08-03
- Last Posted Date
- 2019-09-13
- Lead Sponsor
- Hansa Biopharma AB
- Target Recruit Count
- 2
- Registration Number
- NCT02854059
- Locations
- 🇬🇧
University College London Hospitals NHS, London, Greater London, United Kingdom
A Phase II Study to Evaluate the Efficacy of IdeS to Desensitize Transplant Patients With a Positive Crossmatch Test
Phase 2
Completed
- Conditions
- Interventions
- First Posted Date
- 2016-06-03
- Last Posted Date
- 2021-05-20
- Lead Sponsor
- Hansa Biopharma AB
- Target Recruit Count
- 19
- Registration Number
- NCT02790437
- Locations
- 🇺🇸
Cedars-Sinai Medical Center, Los Angeles, California, United States
🇫🇷Necker Hospital, Paris, France
🇸🇪Uppsala University Hospital, Uppsala, Sweden
Study to Evaluate the Safety, Tolerability, Efficacy and PK of IdeS in Kidney Transplantation
- First Posted Date
- 2015-06-18
- Last Posted Date
- 2018-01-08
- Lead Sponsor
- Hansa Biopharma AB
- Target Recruit Count
- 10
- Registration Number
- NCT02475551
- Locations
- 🇸🇪
Hansa Medical AB, Lund, Sweden
Phase II Study, Evaluation of Safety and Efficacy of IdeS in Chronic Kidney Disease
- First Posted Date
- 2014-08-25
- Last Posted Date
- 2017-03-03
- Lead Sponsor
- Hansa Biopharma AB
- Target Recruit Count
- 8
- Registration Number
- NCT02224820
- Locations
- 🇸🇪
Dept. of Transplant Surgery, Uppsala University Hospital, Uppsala, Sweden
Safety Study on IdeS in Healthy Volounteers
- First Posted Date
- 2013-03-01
- Last Posted Date
- 2017-01-19
- Lead Sponsor
- Hansa Biopharma AB
- Target Recruit Count
- 29
- Registration Number
- NCT01802697
- Locations
- 🇸🇪
Clinical Trial Unit, FoU centrum Skåne, Skåne University hospital, Lund, Sweden
© Copyright 2024. All Rights Reserved by MedPath